Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cetylpyridinium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 4/20 | 0.95 |
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.95 |
| ▸ | ADRA2A known ✓ | P08913 | 2/20 | 0.95 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.95 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.95 |
| ▸ | SLC6A4 known ✓ | P31645 | 2/20 | 0.95 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.95 |
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.95 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.95 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.95 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.95 |
| ▸ | PDE4A known ✓ | P27815 | 1/20 | 0.95 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.95 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.95 |
| ▸ | DRD3 known ✓ | P35462 | 1/20 | 0.95 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.95 |
| ▸ | CACNA1C known ✓ | Q13936 | 1/20 | 0.95 |
| ▸ | SCN5A known ✓ | Q14524 | 1/20 | 0.95 |
| ▸ | HRH3 known ✓ | Q9Y5N1 | 1/20 | 0.95 |
| ▸ | HSP90AA1 known ✓ | P07900 | 2/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28028186 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Hydrochloric Acid SCHEMBL2117173 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Cetylpyridinium SCHEMBL28284539 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Hydrochloric Acid SCHEMBL28283291 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Cetylpyridinium SCHEMBL2774630 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Hydrochloric Acid SCHEMBL28155955 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Cetylpyridinium SCHEMBL28386109 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Cetylpyridinium SCHEMBL27758101 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Hydrochloric Acid SCHEMBL1889300 | 1.00 | ACHE (0.95) | ACHECHRM2ADRA2AADORA3CHRM1 | |
| Hydrochloric Acid SCHEMBL25413606 | 0.98 | ACHE (0.91) | ACHECHRM2ADRA2AADORA3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101932245-A | Protective layer for plants and trees, the production thereof and use thereof | STIFTUNG NANO INNOVATIONS | 2010-12-29 | — | — | CN | claimed |
| CN-115362182-A | Hydrophilic oil-repellent polymers | 住友化学株式会社 | 2022-11-18 | — | — | CN | disclosed |
| CN-113195707-A | Compositions and methods for generating hair cells by upregulation of JAG-1 | 频率治疗公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-109908016-A | Oral care composition and application method | 高露洁-棕榄公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-105848729-B | The composition containing film forming matter comprising polyvinyl acetate and pigment | 高露洁-棕榄公司 | 2019-05-31 | — | — | CN | disclosed |
| CN-108601720-A | oral care product and method | 高露洁-棕榄公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-108601956-A | mouthwash product and method | 高露洁-棕榄公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-108136225-A | ORAL CARE COMPOSITIONS AND METHODS OF USE | 高露洁-棕榄公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-108024925-A | Oral care compositions | 高露洁-棕榄公司 | 2018-05-11 | — | — | CN | disclosed |
| CN-108024919-A | High ph active composition | 高露洁-棕榄公司 | 2018-05-11 | — | — | CN | disclosed |
| CN-107108359-A | Composition for antistatic flooring comprising curable resin | 亚什兰许可和知识产权有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-107106473-A | Oral care product and its use and manufacture method | 高露洁-棕榄公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-106999392-A | Tooth whitening oral care product | 高露洁-棕榄公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-105848729-A | Film forming containing compositions comprising polyvinyl acetate and a pigment | 高露洁-棕榄公司 | 2016-08-10 | — | — | CN | disclosed |
| CN-105828796-A | Tooth whitening oral care product | 高露洁-棕榄公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-105828802-A | Film compositions for oral use | 高露洁-棕榄公司 | 2016-08-03 | — | — | CN | disclosed |
| US-5514647-A | Fibronectin-containing ophthalmic solution, method of preserving an opthalmic solution, and methods of treatment of opthalmic wounds | NEW YORK BLOOD CENTER, INC. (US) | 1996-05-07 | — | — | US | disclosed |
| US-5348939-A | Wound healing agents with sugar, amino acid and lower alkyl p-hydroxybenzoate | NEW YORK BLOOD CENTER, INC. (US) | 1994-09-20 | — | — | US | disclosed |
| EP-0614370-A1 | FIBRONECTIN-CONTAINING OPHTHALMIC SOLUTION, METHOD OF MANUFACTURE OF AN OPHTHALMIC SOLUTION, METHOD OF PRESERVING AN OPHTHALMIC SOLUTION, AND METHODS OF TREATMENT OF OPHTHALMIC WOUNDS | New York Blood Center, Inc. (US) | 1994-09-14 | — | — | EP | disclosed |
| WO-1993010809-A1 | FIBRONECTIN-CONTAINING OPHTHALMIC SOLUTION, METHOD OF MANUFACTURE OF AN OPHTHALMIC SOLUTION, METHOD OF PRESERVING AN OPHTHALMIC SOLUTION, AND METHODS OF TREATMENT OF OPHTHALMIC WOUNDS | NEW YORK BLOOD CENTER, INC. (US) | 1993-06-10 | — | — | WO | disclosed |